超高D-二聚体水平的临床意义
本研究回顾性分析了4年间671例血浆D-二聚体>5000 ng/mL的住院患者,发现静脉血栓栓塞症(VTE)是最常见诊断,其次是癌症和肺炎,61%患者存在多种临床诊断,11.3%未找到明确原因。无临床诊断患者中,D-二聚体>15000 ng/mL组死亡率高达75%。
要点
- D-二聚体>5000 ng/mL时VTE最常见,需同时排查癌症和肺炎。
- 61%患者存在多种临床诊断,11.3%未找到明确原因。
- 无临床诊断者D-二聚体>15000 ng/mL时死亡率达75%。
核心结论
- VTE、癌症和肺炎是超高D-二聚体水平常见伴随疾病。
- D-二聚体>15000 ng/mL时死亡率高,提示严重基础疾病。
研究设计与样本
- 回顾性研究,筛查4年住院患者中血浆D-二聚体>5000 ng/mL者。
- 共纳入671例患者,按D-二聚体水平分层比较临床诊断。
主要发现
- VTE是D-二聚体>5000 ng/mL患者最常见诊断,其次为癌症和肺炎。
- 61%患者存在多种临床诊断,11.3%未找到明确原因。
- 无临床诊断患者中,5000-10000 ng/mL组死亡率为24%。
- 无临床诊断患者中,10000-15000 ng/mL组死亡率为28.6%。
- 无临床诊断患者中,>15000 ng/mL组死亡率为75%。
临床怎么用
- D-二聚体>5000 ng/mL时应全面排查VTE、癌症和肺炎等疾病。
- D-二聚体>15000 ng/mL提示预后不良,需警惕严重基础疾病。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Plasma D-dimer levels >5000 ng/mL are encountered in a number of conditions other than venous thromboembolism (VTE). Recent studies have used plasma D-dimer levels as a prognostic indicator for coronavirus disease 2019 (COVID-19) infection. The implications of abnormal levels are less clear for patients diagnosed with COVID-19 with a baseline elevation in plasma D-dimer levels. In the present study, we reviewed the occurrence of plasma D-dimer levels >5000 ng/mL and investigated the clinical significance of this finding before the onset of the COVID-19 pandemic. METHODS: Inpatient records for a 4-year period were screened for laboratory results of plasma D-dimer levels >5000 ng/mL. The patient data were reviewed for the clinical identifiers commonly associated with elevated plasma D-dimer levels, including VTE, cancer, sepsis, pneumonia, other infection, bleeding, and trauma. The patients were then categorized into groups stratified by the plasma D-dimer level to allow for comparisons between the various clinical diagnoses. RESULTS: A total of 671 patients were included in the present study. VTE was the most common diagnosis for patients with a plasma D-dimer level >5000 ng/mL, followed by cancer and pneumonia. Multiple clinical diagnoses were present in 61% of the patients. No clear cause for the ultra-high plasma D-dimer level could be identified in 11.3% of the patients. Among the patients lacking a clinical diagnosis at discharge, mortality was 24% in the 5000- to 10,000-ng/mL group, 28.6% in the 10,000- to 15,000-ng/mL group, and 75% in the >15,000-ng/mL group. CONCLUSIONS: VTE, cancer, and pneumonia were frequently present when ultra-high plasma D-dimer levels were encountered, and mortality was high when the levels were >15,000 ng/mL. The results from our study from a pre-COVID-19 patient population suggest that ultra-high plasma D-dimer levels indicate the presence of severe underlying disease. This should be considered when using the plasma D-dimer level as a screening tool or prognostic indicator for COVID-19 infection.
引用
- Schafer K, Goldschmidt E, Oostra D, et al. The clinical significance of ultra-high D-dimer levels. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 34171532. doi:10.1016/j.jvsv.2021.06.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。